Navigation Links
AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study
Date:9/28/2007

missed or delayed diagnosis."

Continued Bealer, "A test like AppyScore is a very appealing diagnostic strategy, as it provides an objective, quantitative result that any physician can interpret. In addition, the extreme sensitivity of AppyScore positions it perfectly as screen or triage test. This type of strategy will be a welcomed addition to the diagnostic armamentarium that physicians currently possess for appendicitis, where the current information is frequently subjective, qualitative, and less sensitive."

Trends and Observations from the Study

Comparison with C-reactive protein. C-reactive protein ("CRP") is an acute-phase protein marker that is often used as an aid in the diagnosis of appendicitis. A subset (n=235 patients) of the study also compared AppyScore results to tests based on CRP levels. Results of this study showed that CRP has a relatively poor sensitivity (78%) relative to that of AppyScore (98%) among those with appendicitis, and this performance difference is statistically significant (p < 0.0001). Additionally, CRP and AppyScore values were compared in the subset of 100 normal presumably healthy individuals. Only 46% of these normal donors had negative CRP values compared with 90% of these same normal donors having a negative AppyScore (p < 0.001).

Children 13 year of age and younger. Children 13 years of age and younger are an especially difficult challenge in the diagnosis of appendicitis for several reasons. Due to generally lower body fat in this age group, the CT scan imaging is more challenging. Also, this age group is less able to articulate their condition to the physician. In the present study there were only 32 patients (10% of the 311 total evaluable) in the range of 13 years of age and younger. This 13 and under subset, however, represented a higher percentage of appendectomies (surgeries) (63%), almost double the appendectomy rate in our entire study population (35%). Specifically, for these children there
'/>"/>

SOURCE AspenBio Pharma, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Sygnis Pharma AG announces date for presentation of clinical results
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Africa , Jan. 23, 2015   Leatt Corporation ... personal protective equipment for all forms of sports, including ... Leatt-Brace® neck brace, announced today that the UISP Lega ... now requires all riders to wear a neck brace ...
(Date:1/23/2015)... Tianyin Pharmaceutical Inc. (NYSE Amex: TPI ), ... sale of patented biopharmaceutical medicine, modernized traditional Chinese medicine ... announced the business and development progress at its Jiangchuan ... the September 2014 JCM application (No. 51268) for the ...
(Date:1/22/2015)... , Jan. 22, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ... focus on Omega-3 therapies for cardiovascular disease and overall health ... Company,s accomplishments in 2014 and its outlook for 2015 from ... Fellow Shareholders, We would like to take this ...
Breaking Medicine Technology:Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 3TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7
... April 26 Micromet, Inc. (Nasdaq: MITI ), a biopharmaceutical ... treatment of cancer, today announced that it will host a conference call ... Wednesday, May 5, 2010 , at 8:30 AM ET . , ... To participate in the conference ...
... , April 26 Cornerstone Therapeutics Inc. (Nasdaq: ... developing and commercializing significant products primarily for the respiratory and ... call at 8:00 AM ET on Tuesday, ... the quarter ended March 31, 2010 .  Management will ...
Cached Medicine Technology:Micromet to Report First Quarter 2010 Financial Results on May 5 2Cornerstone Therapeutics to Host First Quarter 2010 Conference Call 2Cornerstone Therapeutics to Host First Quarter 2010 Conference Call 3
(Date:1/22/2015)... January 22, 2015 Woodloch Pines, an ... been selected by TripAdvisor as the number one best large ... best in the world for their annual Travelers’ Choice Awards. ... community . The website is home to millions of unbiased ...
(Date:1/22/2015)... Padre Murphy's and Owner Tom Boyle in Glendale, AZ has ... (PPHA). The PPHA's passion for others' well-being and shared ... treated for obstructive sleep apnea (OSA) has propelled them into ... the valley. The most recent plans for an event will ...
(Date:1/22/2015)... 22, 2015 The Incredible Bulk is a ... to increase lean muscle by up to 30lbs in less ... attention of HealthyandFitZone.com’s Stan Stevenson, prompting an investigative review. , ... a step-by-step, scientific diet formula that allows the body to ...
(Date:1/22/2015)... EAGAN, Minn. (PRWEB) January 22, 2015 Blue ... discover those Minnesotans who exemplify what it means to “Live ... a chance for people to share their stories about how ... adversity or simply inspired others by living in the moment. ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 The federal court ... the U.S. District Court, Southern District of West Virginia has ... in that proceeding’s first bellwether trial. In an Order dated ... new trial after finding that C.R. Bard had not proven ...
Breaking Medicine News(10 mins):Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4
... 5 A failed drug launch can cost,a ... can end,up costing a company more. Leading pharmaceutical ... annual sales with a re-launch, according to a,study ... LLC., As best-in-class pharma companies have demonstrated, ...
... Remain Despite Rising Health Care Costs,Reductions in Federal ... the,continuing challenges of reductions in federal funding and ... remained committed to,providing for the needs of Pennsylvania,s ... The Governor said no Pennsylvanian currently receiving ...
... Researchers at the University of Pennsylvania School of Medicine ... associated with RNA are an important molecular guide to ... Elmer Bobst Professor of Pharmacology, and lead authors Kevin ... lab, report their findings in this week,s early online ...
... zinc supplement help protect young children from malaria" A randomized ... Journal, would suggest the answer is yes. , Jean-Bosco Ouedraogo ... (IRSS) in Bobo Dioulasso, Burkina Faso, and colleagues explain that ... normal function of the immune system, and may even play ...
... on February 14th, VICTORVILLE, Calif., Feb. 5 ... today the Victorville Senior,Valentine,s Day Luncheon. They will host ... 2:00pm at the Victorville Senior Hall., The event ... feature a sit down,meal from Carino,s Italian Grill and ...
... An unexpected finding turned out to be a clue ... St. Louis to propose a new treatment approach for ... To overcome the genetic defect in Niemann-Pick disease, the ... protein molecules through the cell,s quality control machinery. And ...
Cached Medicine News:Health News:Redefining a Product's Identity Key to a Successful Re-Launch 2Health News:Governor Rendell Says 2008-09 Budget Renews Commitment to Vulnerable Pennsylvanians 2Health News:Governor Rendell Says 2008-09 Budget Renews Commitment to Vulnerable Pennsylvanians 3Health News:Governor Rendell Says 2008-09 Budget Renews Commitment to Vulnerable Pennsylvanians 4Health News:RNA-associated introns guide nerve-cell channel production 2Health News:Supplementary approach to malaria 2Health News:Chemical chaperone could open door to treatment of neurological disorder 2Health News:Chemical chaperone could open door to treatment of neurological disorder 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: